Most headlines make billion-dollar beauty acquisitions sound like the ultimate win, build fast, sell big, cash out. We see it differently. In this episode, we share why we turn down investor offers and why outside funding often marks the end of real innovation.We break down what happens when profit-first investors take over: pressure to cut ingredient quality, cheapen packaging, and churn out unnecessary products. We explain why that goes against everything we build at Young Goose, science-backed, high-integrity formulas that put skin longevity first.We talk about the kind of growth we do want, how we protect our creative freedom, and why staying independent keeps our research bold and our products uncompromised.If you want to know what really happens behind the headlines, and why we believe mission matters more than the biggest buyout offer, this episode takes you inside our vision for the future.What's Discussed:(00:08) Why We Refuse Investor Money (Even When It’s Millions)(15:53) The Growth Path That Keeps Our Innovation Alive(20:40) How Our Ingredients Influence the Entire Skincare Industry(22:31) Why We Compare Ourselves to Aesop — Not Rhodes or Rare(24:17) The Real Reason We’re in Skincare (It’s Not the Buyout)Find More from Young GooseThe YouTH Firming Body Cream: Smoother arms, firmer thighs, tighter skin, powered by NAD+ and spermidine. Your body’s anti-aging breakthrough →Body CreamSpermidine Serums: Fewer wrinkles. More collagen. Real skin renewal at the cellular level. The serum your face has been waiting for →Spermidine SerumsUse code PODCAST10 to get 10% off your first purchase, and if you’re a returning customer use the code PODCAST5 to get 5% off at https://www.younggoose.com/ Instagram: @young_goose_skincare

Ask this episode

“What did the council decide on item 42?” — answered with the speaker and the moment.